Pluri PLUR
NASDAQ PLUR
$1.84 +0.08 (+4.55%)
As of: Aug 21, 2026 · 3:59 PM EDT

Pluri (PLUR) Revenue (2011 - 2025)

Pluri (PLUR) posted quarterly Revenue of $198000.0 for Q4 2025, up 7.03% year-over-year from $185000.0 in Q4 2024, and down 37.34% quarter-over-quarter from $316000.0 in Q3 2025.

Pluri (PLUR) Revenue (2011 - 2025) Analysis & Trends

Pluri (PLUR) has reported Revenue for 12 consecutive years, with $198000.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Revenue rose 7.03% year-over-year to $198000.0; the TTM figure through Dec 2025 stood at $1.3 million (up 97.49% YoY), while the FY2025 annual figure was $1.3 million, up 309.82% from the prior year.
  • Revenue slipped to $198000.0 in Q4 2025 per PLUR's latest filing, from $316000.0 in the prior quarter.
  • Across five years, Revenue topped out at $427000.0 in Q1 2025 and bottomed at $2000.0 in Q4 2022.
  • Historically, Revenue has averaged $179800.0 across 4 years, with a median of $111000.0 in 2023.
  • On a YoY basis, Revenue climbed as much as 5150.0% in 2023 and fell as far as 62.82% in 2023.
  • Pluri's Revenue stood at $2000.0 in 2022, then jumped by 5150.0% to $105000.0 in 2023, then jumped by 76.19% to $185000.0 in 2024, then increased by 7.03% to $198000.0 in 2025.
  • Business Quant data shows PLUR's Revenue at $198000.0 in Q4 2025, $316000.0 in Q3 2025, and $398000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 3.33 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 4.29 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.52 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 145.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.71 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.29 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 1.06 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 425.49 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 674.14 Mn
10 Pluri 16.21 Mn 3.72 Mn 86,000.00 198,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 198,000.00
Sep 30, 2025 316,000.00
Jun 30, 2025 398,000.00
Mar 31, 2025 427,000.00
Dec 31, 2024 185,000.00
Sep 30, 2024 326,000.00
Jun 30, 2024 96,000.00
Mar 31, 2024 71,000.00
Dec 31, 2023 105,000.00
Sep 30, 2023 54,000.00
Jun 30, 2023 111,000.00
Mar 31, 2023 87,000.00
Dec 31, 2022 2,000.00
Sep 30, 2022 87,000.00
Mar 31, 2022 234,000.00
Dec 31, 2019 23,000.00
Dec 31, 2018 50,000.00
Sep 30, 2018 4,000.00
Dec 31, 2017 50,000.00
Dec 31, 2015 2.75 Mn